Katherine Fuh, MD, PhD

Professor, Gynecologic Oncology

In vivo genome-wide CRISPR screens in human T cells to enhance T cell therapy for solid tumors.

Wednesday, September 24th, 2025

Systemic Treatment of Ovarian Cancer Recurrence: ASCO Living Guideline, Version 2026.1.0.

Monday, July 13th, 2026

Aging increases ovarian cancer growth, metastasis, and immunosuppression that can be alleviated by inhibiting hedgehog signaling.

Wednesday, July 1st, 2026

Rethinking ovarian cancer III: the past decade and future directions.

Monday, April 13th, 2026

Correction: GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress.

Tuesday, March 3rd, 2026

See all their publications

September 19, 2019 - August 31, 2024 - Role of the microenvironment in ovarian cancer metastasis , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01CA234553